Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-17-000282

EVP, CHIEF COMMERCIAL OFFICER sold 157,540 shares at an average $39.77 ($6,265,095)

  • EVP, CHIEF COMMERCIAL OFFICER acquired 155,580 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER 2017-02-14 Option exercise +87,128 $19.61 $1,708,580 90,759 D
Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER 2017-02-14 Sale −89,088 $39.69 $3,535,573 1,671 D
Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER 2017-02-15 Option exercise +1,700 $19.61 $33,337 3,371 D
Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER 2017-02-15 Sale −1,700 $39.65 $67,405 1,671 D
Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER 2017-02-16 Option exercise +17,421 $19.61 $341,626 19,092 D
Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER 2017-02-16 Option exercise +19,687 $27.20 $535,486 38,779 D
Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER 2017-02-16 Option exercise +29,644 $34.45 $1,021,236 68,423 D
Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER 2017-02-16 Sale −66,752 $39.88 $2,662,116 1,671 D
Derivatives
Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER 2017-02-14 Option exercise · Stock Option (right to buy) −12,747 7,649 D
Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER 2017-02-14 Option exercise · Stock Option (right to buy) −74,381 55,223 D
Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER 2017-02-15 Option exercise · Stock Option (right to buy) −1,700 53,523 D
Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER 2017-02-16 Option exercise · Stock Option (right to buy) −17,421 36,102 D
Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER 2017-02-16 Option exercise · Stock Option (right to buy) −19,687 13,125 D
Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER 2017-02-16 Option exercise · Stock Option (right to buy) −29,644 90,356 D
Open-market sales · 157,540 sh · avg $39.77 · $6,265,095
Loading xslF345X03/form4-02162017_040225.xml…